| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.3M | -87.6% |
| R&D Expense | $58.6M | +2.6% |
| SG&A Expense | $28.5M | +4.4% |
| Operating Income | -$84.8M | -29.1% |
| Pre-tax Income | -$84.0M | -27.9% |
| Income Tax | -$136K | -196.5% |
| Net Income | -$83.8M | -27.4% |
| EPS (Basic) | -$0.99 | +1.0% |
| EPS (Diluted) | -$0.99 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $34.9M | +130.2% |
| Current Assets | $62.3M | -37.0% |
| Total Assets | $71.1M | -35.3% |
| Current Liabilities | $14.7M | -27.2% |
| Total Liabilities | $20.8M | -19.8% |
| Stockholders' Equity | $50.3M | -40.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$80.1M | -49.2% |
| Capital Expenditures | $38K | -93.4% |
| Investing Cash Flow | $57.0M | +352.0% |
| Financing Cash Flow | $42.7M | +2963.7% |
| Free Cash Flow | -$80.2M | -47.7% |
| +1.0% |